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The T-200 (CD45R) family of molecules are expressed with selective isoforms
through a process ofexon splicing on functionally distinct T cell subsets (1-3). Ex-
pression of the higher molecular weight (200,000-220,000 Mr) isoforms on the sur-
face of resting CD4+ T cells has been associated with downregulation of immune
responses (4-7), which may relate to the tyrosine phosphatase activity of the CD45R
complex (8-11). Whether the expression of the higher molecular weight isoforms
recognized by anti-CD45RA (2144) mAbs represents different lineages of T cells
and/or a stage in the sequential pathway of T cell differentiation remains unknown
(4-7). The decreased expression of CD45RA with T cell activation of bulk T cell
populations and the inability ofinvestigators to identify a stable human T cell clone
expressingcell surface CD45RA molecules has been evidence suggestingthat CD45RA
expression may represent a marker of naive T cells, while expression of the lower
molecular weight isoforms of the T-200 complex recognized by anti-UCHL-1 mAb
represents memory T cells (5-7).
We now report the characterization of a smaller subpopulation of T cell clones
that were induced to express the CD45RA molecule with activation by ionomycin.
This CD45RA expression was also upregulated in a specific manner by the cytokines
IL-1 and IL-6. These results indicate CD45RA expression can define T cell lineages
in a subpopulation of activated T cells.
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Materials and Methods
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Cloning.
￿
PBMC were directly cloned at less than one cell per well with 105 autologous,
irradiated (5,000 rad) PBMC and purified PHA (PHA.P) (1.0 jg/ml) (Wellcome Diagnostics,
Beckenham, UK) in 96-well Vbottomed plates in standard media consisting of 10% pooled
human AB serum in RPMI (Whitaker M. A. Bioproducts, Walkersville, MD), 2% gluta-
mine (Gibco Laboratories, Grand Island, NY), and 1% penicillin/streptomycin (Gibco Labora-
tories). 48 h later, 0.1 ml ofmedia containing 10% IL-2 (ABI, Columbia, MD) and 50 U/ml
of rIL-4 (Genzyme, Boston, MA) was added to each well. Cultures were fed with IL-2 and
IL-4 every 3-5 d until approximately day 12, when all the wells were passed to 96-well U-bot-
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tomed plates. Growth-positive wells were scored macroscopically and transferred into Vbot-
tomed plates with 5,000 cloned T cells per well with 105 allogeneic, irradiated (5,000 rad)
mononuclear cells and PRATwith IL-2 plus IL-4. When there were 2-10 x 104 T cellsper
Vbottomed well (usually 3-5 d), clones were transferred to flasks. T cell clones were restimu-
lated every 10-14 d, as above.
Resting T cell clones (stimulated 7 d earlier with PRAT and feeder cells) were activated
with ionomycin (Calbiochem-Behring Corp., La Jolla, CA) (100 ng/ml) and PMA (Sigma
Chemical Co., St. Louis, MO) (1 ng/ml) and incubated for 3 or 12 h. Cytofluorographic anal-
ysis after staining of resting and activated clones was performed by means of either direct
immunofluorescence with phycoerythrin (PE)-conjugated anti-CD45RA' (2H4) mAb (Coul-
ter Immunology, Hialeah, FL) with background fluorescent reactivitydetermined using PE-
conjugated mouse Ig of the same isotype as a control, or in some experiments, by indirect
immunofluorescence (4). Flow cytometric analysis was performed using an Epics C flow cyto-
meter (Coulter Electronics, Hialeah, FL). All incubations were for 30 min with two washes
between steps and before analysis.
Immunoprecipitation.
￿
T cells were labeled by lactoperoxidase-catalyzed iodination, (1) washed,
and solubilized in lysis buffer (1°Jo NP-40 [wt/vol] in 20 ml Tris-HCL buffer, pH 8.0, con-
taining 100 mM NaCl and 1 mM PMSF). The lysate was then incubated with 5 pl of the
mAb 9.4 (a kind gift of Dr. P Martin, Seattle, WA) before precipitating with 50 pl of 10%
(wt/vol) protein A-Sepharose (12). Immunoprecipitates were washed three times in lysis buffer
before analysis on a 5-7% gradient gel.
Cytokines.
￿
T cell clones were purified by density centrifugation on a Ficoll/Hypaque gra-
dient after being stimulated between 7 and 14 d earlier with PHAT and accessory cells ir-
radiated with 5,000 rad. This population consists of only T cells with no viable accessory
cells. 106 T cell clones were incubated with complete media for 18 h at 37'C with IL-1 (3
U/ml; Genzyme), rIL-2 (10 U/ml), rIL-4 (10 U/ml; Genzyme), rIL-5 (1 U/ml), rIL-6 (10
U/ml), and IFN-y (1,000 U/ml; Genzyme) (rIL-2, rIL-5, and rIL-6 were gifts from Drs.
Steven Clark and Ken Jacobs, Genetics Institute, Cambridge, MA), and stained with anti-
2H4 mAb and mouse Ig as described above.
Results
A total of 81 T cell clones were derived from two subjects for examination of
CD45RA expression. In subject Ar, 7/41 T cell clones expressed CD45RA with acti-
vation. Of these, 4/9 (44%)were CD8', and 3/32 (9%) were CD4' . Another series
of T cell clones were generated from subject Re; of which, two offour CD8+ clones
expressed CD45RA with activation while none of the CD4+ clones were positive
(Fig. 1). All ofthe clones expressed high densities of cell surface CD45RO (UCHL-
1) and CDw29 (4B4) molecules both at rest and with activation.
A number of T cell clones expressing CD45RA from subject Re were expanded
to large numbers to further investigate CD45RA regulation. The kinetics of the
CD45RA expression was examined by activating clone Re.F with ionomycin and
PMA. Re.F expressed high densities of cell surface CD45RA within 12 h after acti-
vation, which was not observed among the other T cell clones (shown is clone Re.I,
Fig. 1). Similarly, CD45RA expression in clone Re.F could be induced by ionomycin
alonewithout PMA. In some experiments, CD45RA expressionpersisted throughout
the cell cycle without further augmentation by reactivation, though it was most prom-
inent in the T cell population with the greater forward angle and 90° light scatter
further indicating that activated cells were preferentially induced to express the
CD45RA' complex. These clones were carried in culture for -11 mo before losing
expression of the CD45RA molecule.
The specific isoforms expressed on the cell surface can be identified by immuno-BROD ET AL.
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FIGURE 1 .
￿
Activation of clone Re.F induces the expression ofCD45RA (2H4) molecule . Clone
Re.F and a representative clone, Re .I, were analyzed for the expression ofCD45RA' (2H4) at
rest or after stimulation with ionomycin andPMA for varying lengths of times . Cell numbers
are represented on the vertical axis, and fluorescence, on a logarithmic scale, is on the horizontal
axis . Background staining with ascites did not change after activation .
precipitation using anti-CD45R mAbs (1). As shown in Fig . 2, an additional band
at 200,000M r was seen in activated clone Re.F compared with other anti-2H4- T
cell clones corresponding to the specific isoform of CD45RA+ , confirming the
phenotypic characterization . Expression of the 200,000M r isoform on the surface
ofclone Re .F appeared identical to that observed in resting peripheral bloodTcells .
There was no expression of the highest (220,000M r) molecular weight isoform of
the T-200 complex on clone Re.F .
As activation by ionomycin alone could induce CD45RA+ expression, the higher
molecular weight isoform expression recognized by anti-2H4 mAb may have been
induced by the autocrine release of cytokines . This was directly investigated by cul-
turing the resting clones Re.F andRE.9, 7 d after last stimulation, with either IL-1,
IL-2, IL-4, IL-5, IL-6, or IFN- ,y for 18 h . It was found that IL-1 and IL-6 directly
upregulatedCD45RA+ expression, while the other cytokines did not(shown is Re.F
in Fig . 3) . Similarly, five of the seven clones from subject Ar that could express
CD45RA+ were induced to express CD45RA after incubation with IL-1 (data not
shown) . This demonstrates that IL-1 induction ofCD45RA expression isa property
of a significant subset of humanT cell clones .
FIGURE 2 . Phenotypic expression of CD45RA
(2H4) molecule on Re.F correlates with 200,000M r
isoform of T-200 complex. ThreeT cell clones and
PBMC, activated as described in Fig . 1 for 12 h, were
labeledby lactoperoxidase-catalyzed iodination and
lysed in NP-40 lysis buffer forimmunoprecipitation
as previously described (1) . Each sample was precipi-
tatedwith either normalmouseserum or antiT200 .2150
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FIGURE 3.
￿
Incubation ofcloneRe.F with IL-1 or IL-6 induces CD45RA (2114) expression. Clone
Re.F, 7-10 dafter stimulation, wasincubatedwith thelymphokines as indicated for 18 h at 37°C
andstained with anti-2114 mAbas describedin Fig. 1. rIL-5 andIFN--yhadnoeffect onCD45RA
expression and are not shown. Cell numbers are represented on the vertical axis, and fluores-
cence, on a logarithmic scale, is on the horizontal axis.
TCR genes were examined on genomic DNA to examine whether the CD45RA+
clones expressed TCRa/S or TCRy/& Southern blot analysis showed a normally
rearranged (3chain oftheTCR, indicatinga TCRa/l#heterodimer(datanotshown).
The presence ofasingle rearrangement on Southern analysis also indicated the ab-
sence of contamination by second clones.
Discussion
T cells can be cloned directly from the peripheral blood before other in vitro ma-
nipulation withveryhighcloningefficiency usingPHA andgrowth factors, including
IL-2 and IL-4. Using this method, a panel of T cell clones could be derived that
were representative ofcirculating Tcellswithout regard to preselection by function
or by kinetics ofcell growth. This allowed us to identify a smaller population ofT
cells that could be induced to express the higher molecular weight isoforms ofthe
T-200 complex, CD45RA, recognized bythe anti-2114 mAb. Thesestudiesindicate
that CD45RA (2114) expression can define a T cell lineage in a subpopulation of
T cells that can at times be regulated by IL-1 and IL-6.
Recent evidence has indicated that the CD45 T-200 complex expresses tyrosine
phosphatase activity (8). In addition, CD4 and CD8 molecules are known to as-
sociate with p56Ick protein kinase (9, 10), which can phosphorylate members ofthe
CD3 complex (13). CD45 is thought to function in the regulation of immune re-
sponsesby dephosphorylatingtyrosine residues in target proteins, such asthe 'chain
of the CD3/TCR complex (11, 14). It may be speculated that the ability of IL-1,
IL-6, or ionomycintoinduce CD45RA expression is linked to tyrosine phosphatase
activity, which then impinges on CD4/Ti/CD3 interactions. Further studiesoftyro-
sine phosphatase activity induced by IL-1 or IL-6 signaling in relationship to func-
tional suppression are presently under investigation.
Clear parallels have been demonstrated between the activities of IL-1 and IL-6,
potentially explaining why both cytokines could regulate CD45RA expression in
the present investigation. It isalso possible that IL-1 orionomycin induced CD45RA
expression indirectly by autocrine secretion ofIL-6, as IL-1 is a potent inducer of
IL-6 secretionin manycell types(15). This possibilityis consistent withthe presenceBROD ET AL.
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ofinducibleIL-6 mRNA in clone Re.F (data not shown), though the lack of induc-
ible IL-1 mRNA indicatesthat the effect of IL-6 is not mediated throughIL-1 secretion.
Previous studiesby some laboratories examiningbulk T cell populationssuggested
that expression of the CD45RA molecule disappears with T cell activation (5, 6).
In the present studies, direct single cell cloning has allowed for a more detailed an-
alysis of less frequent cell populations. Moreover, recent work by Rothstein et al.
(16) has shown that 30-50% of 2H4+ T cells stimulated with Con A express the
CD45RA isoforms in a stable fashion (16). These CD45RA+ cells remain function-
ally distinct as suppressor cells, in contrast to CD45RA- cells, which provide
increased levels of help. Nevertheless, these studies in total do not excludethe possi-
bility that CD45RA expression mayalso representasequential differentiationpathway
in certain T cell subsets.
Taken together, these investigations indicate that CD45RA (2H4) expression can
be observed on asubpopulation of long-term T cell clones that can at timesbe regu-
lated by the cytokines IL-1 and IL-6. Moreover, these results may have implications
regarding the regulatory actions of IL-1 and IL-6, with their ability to increase
CD45RA expression in subpopulations of human T cells.
Summary
Whetherthe expression ofhigher molecularweight isoforms oftheT-200 complex
represents different lineages of T cells and/or a sequential stage of the differential
pathway ofT cells has been unclear. Understanding Tcell expression ofhigher mo-
lecular weight isoforms of the T200 complex (CD45R) may be important because
oftheirassociation with regulation of immune responses. By direct single cell cloning,
we observed a number of long-term T cell clones that expressed CD45RA (2H4).
CD45RA expression couldbe furtherregulated by ionomycin or the cytokines IL-1
and IL-6, but not IL-2, IL-4, or IFN-y. These results indicate that CD45RA ex-
pression may define T cell lineages of activated T cells partially controlled by the
cytokines IL-1 and IL-6. Further, these results may associate regulatory actions of
IL-1 and IL-6 with their ability to increase CD45RA expression in subpopulations
of human T cells.
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